Information on and how to use the knowledge portal

Purpose


The primary purpose of this resource is to equip clinical researchers, research coordinators and their teams with the knowledge and practical tools needed to conduct rigorous, ethical and participant-centred clinical trials involving children. It recognizes that paediatric trials present unique challenges, from ethical complexity and regulatory requirements to the practical difficulties of recruitment, consent and sample collection and seeks to provide access to materials and actionable guidance at every stage of the research process. 

This resource does not replace clinical trial design and implementation guidance more broadly. Many core concepts and approaches are applicable to both adult and paediatric research and are not included in detail in this knowledge portal. 

Intended audience

This resource is primarily designed for clinical researchers (including principal investigators and sub-investigators), research coordinators involved in planning and designing clinical trials as well as site administrators and health workers involved in implementing trials in clinical settings.

It will also be of value to ethics committee members and regulatory affairs professionals seeking further knowledge and guidance on various aspects of paediatric clinical research and trial sponsors seeking to understand the specific requirements and challenges of paediatric drug development.

This resource is designed to be used flexibly according to the user’s needs and level of experience. Users may work through the sections sequentially to develop a broad understanding of paediatric clinical research or navigate directly to the topic most relevant to their work. Each section combines concise narrative guidance with links to open-access external resources that enable users to explore concepts in greater depth and apply them in their own settings. These resources include practical tools and implementation guidance as well as foundational and authoritative references for users seeking more detailed information.

The resources within each section are organized into two categories.

  • Key resources are a selection of accessible and practical resources to support learning and application. These may include free online training courses and materials, webinar recordings, tools and templates, summary documents and selected peer-reviewed literature that illustrate or explain key concepts. Most users should start here.
  • Background resources are authoritative and foundational source publications that underpin the guidance presented in the toolkit. These may include regulatory guidelines, legal and policy documents, international standards, technical guidance and other primary or authoritative sources. This is for users who want to explore concepts further.
   

Users are encouraged to consult the relevant regulatory authority in their country or region, since requirements may vary. References to specific regulatory frameworks (such as the European Medicines Agency, the United States Food and Drug Administration and WHO) are provided throughout, but local requirements should always take precedence.

Using the knowledge portal

This resource is designed to be used flexibly according to the user’s needs and level of experience. Users may work through the sections sequentially to develop a broad understanding of paediatric clinical research or navigate directly to the topic most relevant to their work. Each section combines concise narrative guidance with links to open-access external resources that enable users to explore concepts in greater depth and apply them in their own settings. These resources include practical tools and implementation guidance as well as foundational and authoritative references for users seeking more detailed information. 

The resources within each section are organized into two categories:

Key resources

A selection of accessible and practical resources to support learning and application. These may include free online training courses and materials, webinar recordings, tools and templates, summary documents and selected peer-reviewed literature that illustrate or explain key concepts. Most users should start here. 

Background resources

Authoritative and foundational source publications that underpin the guidance presented in the toolkit. These may include regulatory guidelines, legal and policy documents, international standards, technical guidance and other primary or authoritative sources. This is for users who want to explore concepts further. 

Users are encouraged to consult the relevant regulatory authority in their country or region, since requirements may vary. References to specific regulatory frameworks (such as the European Medicines Agency, the United States Food and Drug Administration and WHO) are provided throughout, but local requirements should always take precedence. 

Methods

The knowledge portal was developed through an iterative process of scoping review, content development, expert review and editorial refinement. 

First, a landscape review and targeted web search were conducted to identify publicly available training resources, guidance and other materials relevant to designing and conducting paediatric clinical trials. Based on this review, the core components and subcomponents of clinical trial design and conduct were identified and organized into an initial content outline. The identification of relevant publications was also enriched through expert outreach and screening of references.

Narrative content was then developed based on the identified resources and the agreed content structure. Artificial intelligence tools were used to support drafting, synthesizing and organizing the content, including identifying and incorporating relevant references and links to key resources (see acknowledgement of the use of artificial intelligence). The Global Accelerator for Paediatric Formulations (GAP-f) Clinical Research Coordinator reviewed and edited the initial draft for organization, coherence and accuracy.

The draft was subsequently reviewed by an Advisory Committee comprising subject-matter experts from the Clinical Research Working Group of GAP-f and WHO (see acknowledgements). Reviewers provided detailed comments and suggested revisions, including additions, corrections and restructuring to improve the content and flow. A second draft was developed incorporating these comments and recommendations, together with input from web design consultants regarding the presentation and usability of the content.

The revised draft was shared with the Advisory Committee for verification and additional feedback and subsequently circulated to a broader group of stakeholders to provide an opportunity for final review. Following incorporation of relevant feedback, the content was submitted for WHO editorial review and technical editing, formatting and web development. The final version underwent WHO review and clearance before publication.